MG
Michael Gleeson
SVP, Corp. Accounts

Michael Gleeson insider trades: GenMark Diagnostics (GNMK) stock sales

SVP, Corp. Accounts, GenMark Diagnostics Last trade Feb 26, 2021 106 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
96
Open-market trades
since 2013
1
Company
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

Open-market buys and sales

96 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 26, 2021GNMK↓ Sell$302K
Feb 24, 2021GNMK↓ Sell$75K
Feb 19, 2021GNMK↓ Sell$51K
Jan 25, 2021GNMK↓ Sell$470K
Nov 24, 2020GNMK↓ Sell$43K
Nov 19, 2020GNMK↓ Sell$23K
Aug 25, 2020GNMK↓ Sell$41K
Aug 20, 2020GNMK↓ Sell$26K
May 28, 2020GNMK↓ Sell$27K
May 19, 2020GNMK↓ Sell$17K
Feb 27, 2020GNMK↓ Sell$7K
Feb 25, 2020GNMK↓ Sell$4K
Feb 20, 2020GNMK↓ Sell$37K
Jan 23, 2020GNMK↓ Sell$25K
Nov 26, 2019GNMK↓ Sell$113K
Nov 25, 2019GNMK↓ Sell$15K
Nov 20, 2019GNMK↓ Sell$10K
Aug 27, 2019GNMK↓ Sell$17K
Aug 20, 2019GNMK↓ Sell$11K
May 30, 2019GNMK↓ Sell$11K
May 24, 2019GNMK↓ Sell$7K
May 21, 2019GNMK↓ Sell$12K
May 6, 2019GNMK↓ Sell10b5-1$80K
Apr 15, 2019GNMK↓ Sell10b5-1$75K
Feb 28, 2019GNMK↓ Sell$357K
Feb 25, 2019GNMK↓ Sell$82K
Feb 20, 2019GNMK↓ Sell$13K
Jan 23, 2019GNMK↓ Sell$23K
Nov 27, 2018GNMK↓ Sell$5K
Nov 20, 2018GNMK↓ Sell$9K
Nov 5, 2018GNMK↓ Sell$2K
Aug 24, 2018GNMK↓ Sell$7K
Aug 21, 2018GNMK↓ Sell$13K
Aug 3, 2018GNMK↓ Sell$3K
May 23, 2018GNMK↓ Sell$7K
May 21, 2018GNMK↓ Sell$12K
May 2, 2018GNMK↓ Sell$2K
Mar 2, 2018GNMK↓ Sell$2K
Feb 26, 2018GNMK↓ Sell$20K
Feb 20, 2018GNMK↓ Sell$9K
Feb 2, 2018GNMK↓ Sell$2K
Dec 4, 2017GNMK↓ Sell$2K
Nov 20, 2017GNMK↓ Sell$13K
Nov 2, 2017GNMK↓ Sell$4K
Sep 5, 2017GNMK↓ Sell$4K
Aug 21, 2017GNMK↓ Sell$18K
Aug 2, 2017GNMK↓ Sell$4K
Jun 2, 2017GNMK↓ Sell$5K
May 19, 2017GNMK↓ Sell$25K
May 2, 2017GNMK↓ Sell$5K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Michael Gleeson's insider trades

Michael Gleeson is SVP, Corp. Accounts at GenMark Diagnostics (GNMK). Since Mar 15, 2013, Michael has reported no open-market purchases and 96 sales worth $3.4M on SEC Form 4. There have been no open-market trades in the last 12 months.

2 sales (5% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include grants and awards (9 filings), option exercises (7 filings), other transactions (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GNMK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.